Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History PROF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics PROF

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – CAD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Profound Medical Corp

PROF
Current price
5.81 USD -0.07 USD (-1.18%)
Last closed 8.20 CAD
ISIN CA74319B5027
Sector Healthcare
Industry Medical Devices
Exchange TO
Capitalization 246 800 939 CAD
Yield for 12 month -36.13 %
1Y
3Y
5Y
10Y
15Y
PROF
21.11.2021 - 28.11.2021

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada. Address: 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

34.29 CAD

P/E Ratio

Dividend Yield

Financials PROF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures PROF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+14 631 066 CAD

Last Year

+9 862 270 CAD

Current Quarter

+3 590 639 CAD

Last Quarter

+5 075 665 CAD

Current Year

+9 640 338 CAD

Last Year

+6 003 121 CAD

Current Quarter

+2 538 517 CAD

Last Quarter

+3 457 754 CAD
EBITDA -35 554 659 CAD
Operating Margin TTM -426.02 %
Price to Earnings
Return On Assets TTM -38.54 %
PEG Ratio
Return On Equity TTM -66.36 %
Wall Street Target Price 34.29 CAD
Revenue TTM 11 879 595 CAD
Book Value 1.69 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 82.10 %
Dividend Yield
Gross Profit TTM 8 035 902 CAD
Earnings per share -1.65 CAD
Diluted Eps TTM -1.65 CAD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -269.39 %

Stock Valuation PROF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 11.64
Price Sales TTM 20.78
Enterprise Value EBITDA -7.93
Price Book MRQ 3.54

Technical Indicators PROF

For 52 Weeks

5.59 CAD 15.77 CAD
50 Day MA 7.71 CAD
Shares Short Prior Month 93 927
200 Day MA 9.33 CAD
Short Ratio 10.30
Shares Short 92 488
Short Percent 0.37 %